The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CARA THERAPEUTICS INC | COM | 140755109 | 58,369 | 3,193,057 | SH | SOLE | 3,193,057 | 0 | 0 | ||
| LIVEXLIVE MEDIA INC | COM NEW | 53839L208 | 7,467 | 3,724,138 | SH | SOLE | 3,724,138 | 0 | 0 | ||
| MERSANA THERAPEUTICS INC | COM | 59045L106 | 1,258 | 796,458 | SH | SOLE | 796,458 | 0 | 0 | ||
| NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 52,168 | 3,766,667 | SH | SOLE | 3,766,667 | 0 | 0 | ||
| SENSEONICS HLDGS INC | COM | 81727U105 | 158 | 159,601 | SH | SOLE | 159,601 | 0 | 0 | ||